Infection News

May is Lyme Disease Awareness Month.

The FDA has issued a warning letter to an online pharmacy for allegedly selling unapproved and misbranded drugs, including hydroxychloroquine and chloroquine, for the treatment of COVID-19, lupus, rheumatoid arthritis and other diseases.

Anti-COVID-19 antibody responses are attenuated in patients who receive infliximab for inflammatory bowel disease, according to a speaker at the 2021 Interdisciplinary Autoimmune Summit.

Emerging data are showing solid efficacy and safety of COVID-19 vaccines in individuals with rheumatic and immune-mediated diseases, according to a presentation at the United Rheumatology Spring Virtual conference.

Patients with rheumatoid arthritis in the United States made “substantial” medication changes in the first 3 months of the COVID-19 pandemic, with and without physician guidance, according to data published in Arthritis Care & Research.

Emerging data are beginning to show that COVID-19 can induce autoimmunity in patients without preexisting immune-mediated inflammatory diseases, with consequences that are yet unknown, according to a speaker at the 2021 Interdisciplinary Autoimmune Summit.

The U.S. public health community was unable to foresee the rampant politicization of the COVID-19 pandemic, and was shocked by the initial federal response, according to New York Times bestselling author John M. Barry.

The NIH has closed enrollment to the fourth iteration of the Adaptive COVID-19 Treatment Trial, indicating that neither treatment — baricitinib plus remdesivir or dexamethasone plus remdesivir — outperforms the other.

Clinicians and researchers continue to debate the etiology and treatment paradigms for the severe inflammatory syndrome that impacts some children with COVID-19, according to a speaker at the ACR State-of-the-Art Clinical Symposium.

Given the global deluge of data investigating COVID-19 in patients with rheumatic and immune-mediated diseases, clinicians continue to struggle with divergent evidence and recommendations, noted a speaker at the ACR State-of-the-Art Clinical Symposium.